​​Life Science REIT launches IPO

​​Life Science REIT in the United Kingdom has expressed its intention to launch an IPO on the Alternative Investment Market (AIM) of the London Stock Exchange, according to news sources.

This will be the first London-listed REIT focused on U.K. life-science properties, providing investors with exposure to an attractive and growing real estate sector.

Life Science REIT will target the Golden Triangle, benefitting from assets close to four of the world’s top 10 universities for life-science and global life-science innovation, world-leading research, and teaching hospitals, as well as a supply-and-demand imbalance for specialist properties.

​​Life Science REIT will invest in a diversified portfolio of properties across the United Kingdom, which are typically leased to tenants operating in the life-sciences sector. The company has assembled a £445 million ($614 million) pipeline of projects.

“We are delighted to announce the proposed IPO of Londo